Notch signalling in primary cutaneous CD30+ lymphoproliferative disorders: A new therapeutic approach?

British Journal of Dermatology

Volumn 163, Issue 4, 2010, Pages 781-788

  Kamstrup, M R ^a   Biskup, E ^a   Gniadecki, R ^a,b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

secretase inhibitors; lymphomatoid papulosis; Notch; primary cutaneous anaplastic large cell lymphoma

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR 1; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; GAMMA SECRETASE INHIBITOR I; GAMMA SECRETASE INHIBITOR IX; GAMMA SECRETASE INHIBITOR XX; GAMMA SECRETASE INHIBITOR XXI; MAMMALIAN TARGET OF RAPAMYCIN; NOTCH RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; RAPAMYCIN; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL LINE; CELL VIABILITY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIGENS, CD30; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; NEOPLASM PROTEINS; OLIGOPEPTIDES; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 77957092118     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09915.x     Document Type: Article

References (30)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999 284 : 770 776.
2. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006 7 : 678 689.
3. Ellisen LW, Bird J, West DC et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991 66 : 649 661.
4. Weng AP, Ferrando AA, Lee W et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004 306 : 269 271.
5. Jundt F, Anagnostopoulos I, Forster R et al. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 2002 99 : 3398 3403.
6. Jundt F, Probsting KS, Anagnostopoulos I et al. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood 2004 103 : 3511 3515.
7. Rosati E, Sabatini R, Rampino G et al. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 2009 113 : 856 865.
8. Tohda S, Nara N. Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells. Leuk Lymphoma 2001 42 : 467 472.
9. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768 3785.
10. Kamstrup MR, Ralfkiaer E, Skovgaard GL et al. Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders. Br J Dermatol 2008 158 : 747 753.
11. Davis TH, Morton CC, Miller-Cassman R et al. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 1992 326 : 1115 1122.
12. Schiemann WP, Pfeifer WM, Levi E et al. A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood 1999 94 : 2854 2861.
13. Kamstrup MR, Gjerdrum LM, Biskup E et al. Notch 1 as a potential therapeutic target in cutaneous T-cell lymphoma. Blood 2010 (Epub ahead of print).
14. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 2003 13 : 65 70.
15. Ciofani M, Zuniga-Pflucker JC. Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat Immunol 2005 6 : 881 888.
16. Cullion K, Draheim KM, Hermance N et al. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood 2009 113 : 6172 6181.
17. Palomero T, Sulis ML, Cortina M et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007 13 : 1203 1210.
18. Biggs WH III., Meisenhelder J, Hunter T et al. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 1999 96 : 7421 7426.
19. Curry CL, Reed LL, Golde TE et al. Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells. Oncogene 2005 24 : 6333 6344.
20. Fortini ME. Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat Rev Mol Cell Biol 2002 3 : 673 684.
21. Adams J. The proteasome: a suitable antineoplastic target. Nat Rev Cancer 2004 4 : 349 360.
22. Han J, Ma I, Hendzel MJ et al. The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition. Breast Cancer Res 2009 11 : R57.
23. Qin JZ, Stennett L, Bacon P et al. p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. Mol Cancer Ther 2004 3 : 895 902.
24. Rasul S, Balasubramanian R, Filipovic A et al. Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells. Br J Cancer 2009 100 : 1879 1888.
25. Xiong Y, Hannon GJ, Zhang H et al. p21 is a universal inhibitor of cyclin kinases. Nature 1993 366 : 701 704.
26. Rangarajan A, Talora C, Okuyama R et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 2001 20 : 3427 3436.
27. Tanaka M, Setoguchi T, Hirotsu M et al. Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation. Br J Cancer 2009 100 : 1957 1965.
28. Wang Z, Zhang Y, Li Y et al. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 2006 5 : 483 493.
29. Rangarajan A, Syal R, Selvarajah S et al. Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology 2001 286 : 23 30.
30. Sade H, Krishna S, Sarin A. The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells. J Biol Chem 2004 279 : 2937 2944.